companydata.dkcompanydata.dk

MATRIX PHARMACEUTICALS ApS: Financial statements 2019

CVR: 29625867

Source: annual report 2019, Danish Business Authority

01/01/201931/12/2019

MATRIX PHARMACEUTICALS ApS (CVR 29625867) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK 35,458 and a net result of DKK -310,051 compared with EUR -637,810 the year before. Equity in the 2019 report amounted to DKK -2,185,383.

Gross Profit
DKK 35,458
Profit/Loss
DKK -310,051
Equity
DKK -2,185,383
Total Assets
DKK 166,770

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2019-35 t.-310 t.-2.2 mio.-
2018-56 t. EUR--638 t. EUR-1.9 mio. EUR-
2017-267 t.-369 t.-1.2 mio.-
2016--40 t.-338 t.459 t.-
2015-450 t.211 t.797 t.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Screen every Danish company

Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.

Try company screening

Events in 2019

MATRIX PHARMACEUTICALS ApS: The 2018 annual report is outJun 6, 2019

MATRIX PHARMACEUTICALS ApS has published its annual report for 2018. Revenue came to DKK -55,731, and the net result was DKK -637,810.

About MATRIX PHARMACEUTICALS ApS

MATRIX PHARMACEUTICALS ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2006. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Karsten Høilund Skafte. The board consists of Karsten Høilund Skafte. The company is owned by Karsten Høilund Skafte and KHS HOLDING ApS. The company has 1 employee (2018). In 2025, the company reported revenue of DKK 1,090,380 and a net result of DKK 589,123 compared with DKK 440,028 the year before. Equity in the 2025 report amounted to DKK 589,123.

Source: annual report 2025, Danish Business Authority